Revolution? What revolution?
Bryter Health and Pharma
We use innovative statistical, digital and behavioral change approaches to better inform pharmaceutical decision-making
Build it and they will come. They didn't. COVID did. And they left again.
This newsletter brings fresh insight into how technological innovation (and investment) alone will not bring the [much hyped] revolution..
The 'Digital Health. Revolution?!?' newsletter will publish NEW RESEARCH and analysis, detailing the perspectives of multiple global stakeholders. Identifying the drivers and barriers to adoption of digital health solutions.
Bryter Health and Pharma is a global insights consultancy working in biopharma and consumer technology. Focused on human needs and behavioral change. Bryter has researched the intersection of healthcare and technology from its foundation in 2010.
We have been studying the impact of the pandemic on the acceptance and usage of digital health globally.
Using a combination of advanced analytics and behavioral science frameworks, to derive new insight from over 25,000 primary research interviews conducted with:-
Assessing from multiple viewpoints, how usage, attitudes and [digital health] behaviors have changed (if at all) following the pandemic, and as technology and products have advanced from 'tracking' to intervention, management and treating disease through digital therapeutics (DTx).
领英推荐
And WHY?
The 'Digital Health Revolution?!?' Newsletter
Over the coming weeks, we will publish the findings from NEW RESEARCH that will:-